Antibody-Drug Conjugate Ups PFS in Untreated Hodgkin ' s (CME/CE)

(MedPage Today) -- Two-year progression-free survival came in at 82.1%
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news